Literature DB >> 8102373

Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157.

A Thomas1, H R Smith, B Rowe.   

Abstract

Digoxigenin-labelled oligonucleotide DNA probes specific for B-subunit genes of Vero cytotoxin 2 (VT2) and a variant of VT2 (VT2vha) were used to differentiate 116 strains of Escherichia coli serogroup O157 belonging to phage types 1, 2, 4, 8, 14, and 49. Of these strains, 38% had sequences for both VT2 and VT2vha, 38% had sequences for VT2 only, and 24% had sequences for VT2vha only. Oligonucleotide probe hybridization subdivided strains of all of the phage types except phage type 1. The greatest variation in toxin gene pattern was observed with strains of phage type 14, for which there were six distinct patterns when the presence or absence of VT1 genes was also considered. Two strains from each phage type group were examined for bacteriophages encoding VT production. Two of the six VT2vha-producing strains carried phage from which DNA hybridized with the VT2vha-specific probe. Phages were not detected in the remaining four VT2vha strains, suggesting that genes may be chromosomally located or associated with a defective prophage. In contrast, seven of the eight VT2 strains carried phages from which DNA hybridized with the VT2-specific probe. Two strains of E32511 (O157:H-) were also investigated. One strain (E32511A) possessed gene sequences for both VT2 and VTvha and was shown to carry phage possessing gene sequences for VT2. With strain E32511B, however, phages were not detected and DNA hybridized only with the VT2vha probe. Analysis of total genomic DNA digested with restriction endonuclease EcoRI showed that polymorphisms were seen with VT2 strains and not with VT2vha strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102373      PMCID: PMC265617          DOI: 10.1128/jcm.31.7.1700-1703.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 2.  Vero cytotoxin-producing strains of Escherichia coli.

Authors:  H R Smith; S M Scotland
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

Review 3.  The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis.

Authors:  L W Riley
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

4.  Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  S D Tyler; W M Johnson; H Lior; G Wang; K R Rozee
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Extended phage-typing scheme for Escherichia coli O157:H7.

Authors:  R Khakhria; D Duck; H Lior
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

6.  Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family.

Authors:  V P Gannon; C Teerling; S A Masri; C L Gyles
Journal:  J Gen Microbiol       Date:  1990-06

7.  Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.

Authors:  H Ito; A Terai; H Kurazono; Y Takeda; M Nishibuchi
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

8.  Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes.

Authors:  G A Willshaw; H R Smith; S M Scotland; A M Field; B Rowe
Journal:  J Gen Microbiol       Date:  1987-05

9.  Comparison of Vero-cytotoxin-encoding phages from Escherichia coli of human and bovine origin.

Authors:  P J Rietra; G A Willshaw; H R Smith; A M Field; S M Scotland; B Rowe
Journal:  J Gen Microbiol       Date:  1989-08

10.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91.

Authors:  A Thomas; H Chart; T Cheasty; H R Smith; J A Frost; B Rowe
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

View more
  17 in total

Review 1.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.

Authors:  D Reymond; M A Karmali; I Clarke; M Winkler; M Petric
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.

Authors:  M Bielaszewska; I Clarke; M A Karmali; M Petric
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome.

Authors:  A Thomas; T Cheasty; H Chart; B Rowe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

5.  Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.

Authors:  A Thomas; T Cheasty; J A Frost; H Chart; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

6.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe.

Authors:  A E Heuvelink; N C van de Kar; J F Meis; L A Monnens; W J Melchers
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

8.  Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.

Authors:  M A Karmali; M Petric; M Bielaszewska
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

9.  Genotyping male-specific RNA coliphages by hybridization with oligonucleotide probes.

Authors:  F C Hsu; Y S Shieh; J van Duin; M J Beekwilder; M D Sobsey
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

10.  Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR.

Authors:  Gehua Wang; Clifford G Clark; Frank G Rodgers
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.